Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1641281 · FYE Dec 31 · Prices AT CLOSE 2026-08-18 (USD) Last $3.18 · Day −0.71% · Mkt cap $6M · 1Y −37.3% · Off 52W high −55.9% · Vol (1Y) 74.5% Price2023-08-18 → 2026-08-18 BOLT close: $23.0 on 2023-08-18 to $3.2 on 2026-08-18. Split-adj closes · 240 of 2,600 · price returnⓘ At a glance | Short interest0.2% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)−2.16% | | Top-10 13F concentration85.5% | | Next report (est.)2026-11-10 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$4.7M | | Earnings (TTM)-$28.7M | | ROE−79.7% | | Net margin−433.7% | | ROIC−642.9% | | Sales growth 3Y10.3% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−41.9% | | 1Y−37.3% | | 3Y−86.2% | | 5Y−98.8% | | 10Y−99.5% | | Since incept. (ann.)−23.3% |
Price return · from 2010-01-12ⓘ Risk | Ann. volatility (1Y)74.5% | | Ann. volatility (3Y)67.6% | | Sharpe (1Y)−0.27 | | Sharpe (3Y)−0.64 | | Max drawdown (1Y)−55.2% | | Max drawdown (3Y)−89.4% | | Beta (3Y vs SPY)1.35 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Sofinnova Investments, Inc. | 137,721 | $556,393 | 7.17% | +0.0% | | RENAISSANCE TECHNOLOGIES LLC | 77,225 | $311,989 | 4.02% | +40.3% | | Vivo Capital, LLC | 72,414 | $292,553 | 3.77% | +0.0% | | Pivotal bioVenture Partners Investment Advisor LLC | 42,581 | $172,027 | 2.22% | −55.0% | | T3 Companies, LLC | 38,000 | $153,520 | 1.98% | +0.0% | | Board of Trustees of The Leland Stanford Junior University | 35,977 | $145,347 | 1.87% | +0.0% | | Pfizer Inc | 31,305 | $137,116 | 1.63% | +0.0% | | Lynx1 Capital Management LP | 30,800 | $124,432 | 1.60% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-11 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-11 | −$4.57 | — | $5,000 | −99.7% | | 2026-03-31 | 2026-05-12 | −$4.31 | — | $26,000 | −97.9% | | 2025-12-31 | 2026-03-12 | — | — | $2.5M | — | | 2025-09-30 | 2025-11-12 | −$3.72 | — | $2.2M | +90.1% |
As-reported XBRL · next 2026-11-10 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
